Serological biomarkers for management of primary sclerosing cholangitis
Dávid Tornai(Beth Israel Deaconess Medical Center), Mária Papp(University of Debrecen), Péter L. Lakatos(McGill University), Peter Laszlo Ven(University of Pecs)
Cited by 24
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
|Journal of Crohn s and Colitis|2021|540
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
|World Journal of Gastroenterology|2008|445